Clinical Trials Directory

Trials / Unknown

UnknownNCT01867840

Role of ASICs in Human Inflammatory Pain

Study of the Role of Acid Sensing Ion Channels (ASICs) in Human Inflammatory Pain

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In recent years, ion channels have emerged as new therapeutic targets for pain. Among these channels, ASICs (Acid Sensing Ion Channels) are of particular interest because they are directly activated by extracellular acidity, which is a major cause of pain. Indeed, many painful conditions such as ischemia, inflammation, tumor development or tissue incision are accompanied by tissue acidification. ASIC are excitatory ion channels that are expressed in neurons, including nociceptive sensory neurons. In humans, the use of amiloride, a nonspecific inhibitor of ASICs, has demonstrated their role in the perception of pain induced by subcutaneous injections of acidic solutions. ASICs thus appear as new candidates capable of mediating pain in humans. A growing number of data suggests that, in addition to protons, ASICs may also be activated by one or more endogenous compounds produced during inflammation. The purpose of this research project is to identify these compounds by testing the effects of human inflammatory exudates on ASICs activity. The discovery of such compounds would definitely validate ASICs as novel therapeutic targets for pain treatment in humans

Conditions

Timeline

Start date
2012-11-01
Primary completion
2014-12-01
Completion
2018-12-01
First posted
2013-06-04
Last updated
2016-10-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01867840. Inclusion in this directory is not an endorsement.

Role of ASICs in Human Inflammatory Pain (NCT01867840) · Clinical Trials Directory